tiprankstipranks

Jonathan Root Insider Profile

11 Followers
Jonathan Root, Director at OncoMed Pharma, holds 541.48K shares in Inari Medical (Ticker: NARI), holds 2.27M shares in ARS Pharmaceuticals (Ticker: SPRY), holds 15.63K shares in Edgewise Therapeutics (Ticker: EWTX).
tipranks
Jonathan Root

Jonathan Root
OncoMed Pharma (OMED)
Director

Ranked #965 out of 98,743 Corporate Insiders

Profitable Transactions

80%
12 out of 15 Profitable Transactions

Average Return

+49.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$53M
42.75%
38.86%
17.77%
0.62%
A breakdown of Jonathan Root's holdings

Insider Roles

Inari Medical
(NARI)
Director
ARS Pharmaceuticals
(SPRY)
Director
eFFECTOR Therapeutics
(EFTR)
Director, Ten Percent Owner
Edgewise Therapeutics
(EWTX)
Director
Roles that Jonathan Root holds in companies

Most Profitable Insider Trade

Stock:
Inari Medical
(NARI)
Rating:Informative Buy
Date:May 27, 2020 - May 27, 2021
Return:+106.50%
The most profitable trade made by Jonathan Root

Jonathan Root's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
OMED
OncoMed Pharma
Apr 23, 2019
Uninformative Sell
$0.00
Inari Medical
Apr 26, 2024
Director
Uninformative Buy
174.98K
$22.64M
ARS Pharmaceuticals
Mar 18, 2022
Director
Informative Buy
36.05K
$20.58M
Edgewise Therapeutics
Feb 28, 2022
Director
Uninformative Sell
$326.41K
eFFECTOR Therapeutics
Dec 06, 2021
Director, Ten Percent Owner
Informative Sell
46.08K
$9.41M
List of latest transactions for each holding click on a transaction to see Jonathan Root's performance on stock

Jonathan Root insider profile FAQ

What is the percentage of profitable transactions made by Jonathan Root?
The percentage of profitable transactions made by Jonathan Root is 80%.
    What is the average return per transaction made by Jonathan Root?
    The average return per transaction made by Jonathan Root is 49.30%.
      What stocks does Jonathan Root hold?
      Jonathan Root holds: OMED, NARI, SPRY, EWTX, EFTR stocks.
        What was Jonathan Root’s latest transaction?
        Jonathan Root latest transaction was an Uninformative Buy of $174.98K.
          What was Jonathan Root's most profitable transaction?
          Jonathan Root’s most profitable transaction was an Informative Buy of NARI stock on May 27, 2020. The return on the trade was 106.50%.
            What is Jonathan Root's role in OncoMed Pharma?
            Jonathan Root's role in OncoMed Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.